PAR paradigm biopharmaceuticals limited..

General OA media and info, page-433

  1. 779 Posts.
    lightbulb Created with Sketch. 325

    Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort

    Pubmed link : https://pubmed.ncbi.nlm.nih.gov/37258065/


    https://hotcopper.com.au/data/attachments/5823/5823965-95d74a80c7e8e927566bceb713cecfc3.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
43.3¢
Change
-0.008(1.70%)
Mkt cap ! $171.8M
Open High Low Value Volume
44.5¢ 44.5¢ 42.5¢ $118.4K 275.0K

Buyers (Bids)

No. Vol. Price($)
5 26779 43.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.5¢ 8300 4
View Market Depth
Last trade - 11.47am 16/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.